HomeRCUS • NYSE
add
Arcus Biosciences Inc
Previous close
$15.39
Day range
$15.55 - $15.73
Year range
$12.95 - $20.31
Market cap
1.42B USD
Avg Volume
579.13K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 39.00M | 34.48% |
Operating expense | 135.00M | 31.07% |
Net income | -93.00M | -24.00% |
Net profit margin | -238.46 | 7.80% |
Earnings per share | -1.02 | 1.92% |
EBITDA | -104.00M | -28.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 969.00M | 4.19% |
Total assets | 1.19B | -2.79% |
Total liabilities | 551.00M | -15.75% |
Total equity | 635.00M | — |
Shares outstanding | 91.43M | — |
Price to book | 2.21 | — |
Return on assets | -21.38% | — |
Return on capital | -37.75% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -93.00M | -24.00% |
Cash from operations | -94.00M | -64.91% |
Cash from investing | 63.00M | 142.31% |
Cash from financing | 2.00M | -91.30% |
Net change in cash | -29.00M | -262.50% |
Free cash flow | -33.25M | -7.69% |
About
Founded
2015
Website
Employees
577
